Current Opinion in Endocrinology Diabetes and Obesity

Papers
(The TQCC of Current Opinion in Endocrinology Diabetes and Obesity is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?38
Obesity and infertility: a double whammy33
Maximizing diabetes education efforts in vulnerable populations – newer delivery concepts33
Updates in thyroid healthcare delivery: advancing patient-centered care32
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome29
Advances in assessment and treatment of bone, mineral and parathyroid disorders27
Nutrition and thyroid disease26
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health26
Editorial introduction25
Editorial introductions24
Editorial introduction24
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?20
Financial toxicity in thyroid cancer survivors20
Recent advances in anaplastic thyroid cancer management20
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis20
Preventing type 1 diabetes development and preserving beta-cell function19
An update on bone in diabetes19
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency18
Update on fracture risk assessment in osteoporosis17
Gastrointestinal hormones and regulation of gastric emptying16
Editorial introduction16
Fibrous dysplasia in children and its management14
Interactions between antidiabetes medications and heart–brain axis14
The use of anabolic agents in the treatment of osteoporosis: a clinical update14
Lipidomics in diabetes13
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia13
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease12
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks12
Long-acting amylin analogues for the management of obesity12
Epidemiologic changes in thyroid disease12
Assisted reproductive technology outcomes and management considerations for people with epilepsy12
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?12
The uncommon forms of congenital adrenal hyperplasia11
Type 2 diabetes: a contemporary view from the Asian lens11
Precision medicine in diabetes care11
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease10
An update on investigation and management of renal bone disease10
Growth and development in type 1 diabetes10
A short history of saturated fat: the making and unmaking of a scientific consensus10
Legislation, medicine, and politics: care for gender diverse youth10
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders10
Editorial introductions10
Glucocorticoid withdrawal syndrome: what to expect and how to manage10
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation9
Adrenal insufficiency and pregnancy9
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment9
Editorial introductions9
Editorial introductions9
Novel techniques for assessment of bone tissue material properties9
Indications for testosterone therapy in men9
Microplastics, cardiometabolic risk, genetics and Alzheimer's disease8
Time to cycle regularity and health risks8
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective8
Early anthropometric indicators of type 2 diabetes mellitus8
The interaction between gut microbiome and bone health8
Multifactorial chylomicronemia syndrome8
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety7
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?7
Advanced imaging and theranostics in thyroid cancer7
Type 2 diabetes mellitus and cognitive function: understanding the connections7
0.041892051696777